ALLERO THERAPEUTICS
Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders. Based on research by the founders and their collaborators the team has identified a novel specific immunotherapy approach based on antigen-specific tolerance induction. The approach defines a platform technology which is broadly applicable to a range of clinical indications with profound unmet medical need.
ALLERO THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2016-01-01
Address:
Rotterdam, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.allerotherapeutics.com
Total Employee:
101+
Status:
Active
Total Funding:
2.57 M EUR
Technology used in webpage:
Euro Google Google Cloud Wix
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Relevium Medical
Relevium Medical is a biopharmaceutical company offering medicines for osteoarthritis.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Swedish Orphan Biovitrum
International Pharmaceutical Manufacture
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
Current Employees Featured
Kees Leenhouts Co-Founder/CTO/COO @ Allero Therapeutics
Co-Founder/CTO/COO
2016-11-01
Emil Pot Co-Founder & CEO @ Allero Therapeutics
Co-Founder & CEO
2016-11-01
Poul Sørensen Co-Founder & CSO @ Allero Therapeutics
Co-Founder & CSO
2016-11-01
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - Allero Therapeutics
Swanbridge Capital
Swanbridge Capital investment in Seed Round - Allero Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Allero Therapeutics
Official Site Inspections
http://www.allerotherapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Allero Therapeutics"
Restoring Immune Tolerance Curing Disease | Allero …
Allero Therapeutics develops next generation immunotherapies for allergic and autoimmune disease patients. Its proprietary SOMIT (Specific OroMucosal ImmunoTherapy) technology is designed to induce long-lasting antigen …See details»
Allero Therapeutics - Crunchbase Company Profile
Contact Email info@allerotherapeutics.com Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies …See details»
TEAM - Allero Therapeutics
>25 years of Pharma/Biotech R&D experience in immunotherapy. Senior Management at ALK, Stallergenes, LEO Pharma, Micromet, Pharmacia. P rofessor of Biomedicine, PhD.See details»
Allero Therapeutics BV - LinkedIn
Allero Therapeutics is a Dutch biotech company that develops next generation immunotherapies for immune mediated disorders. Our goal is to develop novel targeted treatments that induce …See details»
Allero Therapeutics - PitchBook
Allero Therapeutics General Information Description. Developer of immunotherapies intended for immune-mediated disorders. The company offers non-invasive, patient-friendly treatments …See details»
Allero Therapeutics BV - Drug pipelines, Patents, …
Www.allerotherapeutics.com. Startups | Holding Company | 2016 | Netherlands | 100-250 | www.allerotherapeutics.com. Last update 07 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. ... The statistics for drugs in the …See details»
Allero Therapeutics - Company Profile - Tracxn
Mar 9, 2025 Allero Therapeutics - Developer of immunotherapies for allergy and autoimmune disease. Raised funding over 4 rounds from 4 investors. Founded by Emil Pot, Kees …See details»
Allero Therapeutics - Overview, News & Similar companies
Who is Allero Therapeutics. Allero Therapeutics was founded in November 2016 and seed-financed in 2019 by Curie Capital and Swanbridge Capital. Allero Therapeutics is an immun …See details»
Allero Therapeutics Overview | SignalHire Company Profile
Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders.\n\nBased on research by the founders and …See details»
Allero Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Allero Therapeutics. See Allero Therapeutics company profile and funding data.See details»
ALLERO THERAPEUTICS - VentureRadar
Website: https://www.allerotherapeutics.com/ Develops next-generation immunotherapies for allergic and autoimmune diseases, focusing on food-related disorders using ...See details»
Allero Therapeutics - Products, Competitors, Financials, Employees ...
Allero Therapeutics is a biotech company focused on developing next-generation immunotherapies for immune-mediated disorders. Use the CB Insights Platform to explore …See details»
Allero Therapeutics | EU-Startups
Articles about Allero Therapeutics: June 14, 2023 74 Top Biotechnology Startups and Companies in The Netherlands (2021); November 18, 2022 Weekly funding round-up! All of the European …See details»
Allero Therapeutics and Abbreos join forces to clinically develop …
Email: pot@allerotherapeutics.com www.allerotherapeutics.com Email: rbuchanan@abbreos.com www.abbreos.com Media Inquiries akampion Dr. Ludger Wess / Ines-Regina Buth Managing …See details»
Allero Therapeutics - Craft
Allero Therapeutics is a biopharmaceutical company that develops immunotherapies for allergic and autoimmune disease patients. Its proprietary SOMIT (Specific OroMucosal …See details»
TECHNOLOGY - Allero Therapeutics
Allero’s proprietary SOMIT (Specific Oromucosal Immunotherapy) technology combines a tolerance-inducing agent with targeted delivery of specific antigens to the oral mucosa, an …See details»
Company News: Allero Therapeutics and Abbreos Join Forces to
Tuesday, 24. November 2020 Company News: Allero Therapeutics and Abbreos Join Forces to Clinically Develop COVID-19 Program. Allero Therapeutics BV, a Belgian-Dutch oromucosal …See details»
Allero Therapeutics Expands Management Team with Two Key Hires
Dec 15, 2020 www.allerotherapeutics.com . Media Inquiries. akampion. Dr. Ludger Wess / Ines-Regina Buth. Managing Partners. info@akampion.com. Tel. +49 40 88 16 59 64 / Tel. +49 30 …See details»
Allero Therapeutics and Abbreos Join Forces to Clinically Develop …
Nov 24, 2020 ### More information: Email: pot@allerotherapeutics.com www.allerotherapeutics.com Email: rbuchanan@abbreos.com www.abbreos.com Media …See details»
Allero Therapeutics Receives EIC Horizon Grant to Advance
Thursday, 24. November 2022 Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease – Specific OroMucosal ImmunoTherapy (SOMIT) for celiac …See details»